| Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | |
|---|---|---|---|---|---|
Promoter | - | - | - | - | - |
Foreign | 0% | 0% | 0% | 0% | 0% |
Indian | 58.89% | 58.79% | 58.75% | 58.75% | 58.72% |
Total Promoter | - | - | - | - | - |
Institutions | 19.99% | 20.14% | 19.93% | 20.14% | 21.32% |
Non-Institutions | 21.01% | 21.02% | 21.27% | 21.06% | 19.91% |
Total Non-Promoter | 41% | 41.17% | 41.21% | 41.21% | 41.24% |
Custodian | 0.09% | 0.02% | 0.03% | 0.03% | 0.03% |
Total | 100% | 100% | 100% | 100% | 100% |
The company has a strong foothold in the Indian pharma market as well as in the international market where it sells its products in more than 55 countries
Indoco Remedies stated that it will respond to the Form 483 observations within the prescribed timeline.
Here are some of the stocks that may see significant price movement today: IndusInd Bank, Hindustan Zinc, Thermax, etc.
Indoco Remedies will also continue providing products to its existing B2B customers under existing deals.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
